Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A

Cancer Immunology, Immunotherapy

Volumn 42, Issue 2, 1996, Pages 81-87

  Fagerberg, Jan ^a   Ragnhammar, Peter ^a   Liljefors, Maria ^a   Hjelm, Anna Lena ^a   Mellstedt, Håkan ^a   Frödin, Jan Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal carcinoma; GM CSF; Idiotypic network; Monoclonal antibodies

Indexed keywords

AUTOANTIBODY; EDRECOLOMAB; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; COLORECTAL CARCINOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; AUTOANTIBODIES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY; MALE; MICE; MIDDLE AGED; NEOPLASMS; RECOMBINANT FUSION PROTEINS;

EID: 0030010162     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050255     Document Type: Article

References (47)

1. 2A isotype containing increased numbers of macrophages activated for distinctive form of antibody dependent cytolysis. Proc Natl Acad Sci USA 81:3506
2. Austin EB, Robins RA, Durrant LG, Price MR, Baldwin RW (1989) Human monoclonal anti-idiotypic antibody to the tumour associated antibody 79IT/36. Immunology 67:525
3. Baker TS, Begent RHJ, Dewji MR, Conlan J, Secher DS (1991) Characterization of the antibody response in patients undergoing radioimmunotherapy with chimeric B72.3. Antibody Immunoconjugates Radiopharm 4:799
4. Bruck C, Sung Co M, Slaoui M, Gaulton GN, Smith T, Fields BN, Mullins JI, Greene MI (1986) Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparision to the sequence of the external antigen. Proc Natl Acad Sci USA 83:6578
5. Cheung N-K, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM (1994) Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer Res 54:2228
6. Cleave VH van, Naeve CW, Metzger DW (1988) Do antibodies recognize amino acid side chains of protein antigens independently of the carbon backbone? J Exp Med 167:1841
7. Douillard JY, Lehur PA, Vignoud J, Blottiere H, Maurel C, Thedrez P, Kremer M, Le Mevel B (1986) Monoclonal antibodies specific immunotherapy of gastrointestinal tumors. Hybridoma 5:139
8. Durrant LG, Buckley TJD, Demon GWL, Hardcastle JD, Sewell HF, Robins RA (1994) Enhanced cell-mediated tumour killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res 54:4837
9. 3) lead to tumour regression after mAb therapy? Cancer Immunol Irnmunother 37:264
10. 3) of immportance for tumour response to mAb therapy? Cancer Immunol Irnmunother 38:149
11. Fagerberg J, Hjelm A-L, Ragnhammar P, Frödin J-E, Mellstedt H (1995) Tumor regression in monoclonal antibody treated patients correlates with the presence of anti-idiotype reactive T lymphocytes. Cancer Res 55:1824
12. Fagerberg J, Steinitz M, Wigzell H, Askelöf P, Mellstedt H (1995) Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma associated antigen in patients. Proc Natl Acad Sci USA 92:4773
13. Fagreus A, Espmark JÅ, Jonsson J (1965) Mixed haemadsorption: a mixed anti-globulin reaction applied to antigens on a glass surface. Immunology 9:161
14. Frödin J-E, Harmenberg U, Biberfeld P, Christensson B, Lefvert A-K, Rieger Å, Shetye J, Wahren B, Mellstedt H (1988) Clinical effects of monoclonal antibodies (mAb 17-1A) in patients with metastatic colorectal carcinoma. Hybridoma 7:309
15. Frödin J-E, Lefvert A-K, Mellstedt H (1990) Pharmacokineties of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules. Cancer Res 50:4866
16. 1). Relation to the clinical outcome - an important antitumoural effector function? Hybridoma 10:421
17. Herlyn DM, Koprowski H (1981) Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity. Int J Cancer 27:769
18. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1979) Colorectal carcinoma-specific antigen detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76:1438
19. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol 125:373
20. Jones PC, Sze LL, Liu PY, Mortin DL, Irie RF (1981) Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst 66:249
21. Kennedy RC, Dreesman GR, Butel JS, Lanford RE (1985) Suppression of in vivo tumour formation induced by simian virus 40 - transformed cells in mice receiving anti-idiotypic antibodies. J Exp Med 161:1432
22. Khazaeli MB, Saleh MN, Liu T, Kaladas PM, Gilman SC, LoBuglio AF (1992) Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody. J Clin Immunol 12:116
23. Klein G, Sjögren HO, Klein E, Hellström KE (1960) Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res 20:1561
24. Koprowski H, Herlyn D, Lubeck M, DeFreitas E, Sears HF (1984) Human anti-idiotype antibodies in cancer patients: is the modulation of the immune response beneficial for the patients? Proc Natl Acad Sci USA 81:216
25. LoBuglio AF, Saleh M, Peterson L, Wheeler R, Carrano R, Huster W, Khazaeli MB (1986) Phase I Clinical trial of CO17-1A monoclonal antibody. Hybridoma 5:117
26. LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci USA 86:4220
27. Magdelénat H (1992) Tumor markers in oncology: past, present and future. J Immunol Methods 150:133
28. 2). Int J Cancer 48:344
29. Mellstedt H, Frödin J-E, Masucci G, Ragnhammar P, Fagerberg J, Hjelm A-L, Shetye J, Wersäll P, Österborg A (1991) The therapeutic use of monoclonal antibodies in colorectal carcinoma. Semin Oncol 18:462
30. Morrissey PJ, Bressler L, Park LS, Alpert A, Gillis S (1987) Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol 139:1113
31. Nelson KA, George E, Swenson C, Forstrom JW, Hellström KE (1987) Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells. J Immunol 139:2110
32. Ragnhammar P, Fagerberg J, Frödin J-E, Hjelm A-L, Lindemalm C, Magnusson I, Masucci G, Mellstedt H (1993) Effect of the monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma - long lasting, complete remissions can be induced. Int J Cancer 53:751
33. Ragnhammar P, Fagerberg J, Frödin J-E, Wersäll P, Hansson L-O, Mellstedt H (1995) GM-CSF augmented the induction of antibodies, especially anti-idiotypic antibodies to therapeutic monoclonal antibodies. Cancer Immunol Immunother 40:367
34. Ragnhammar P, Frödin J-E, Hjelm A-L, Fagerberg J, Wersäll P, Lindemalm C, Magnusson I, Ewerth S, Ahlberg J, Thor K, Secher E, Mellstedt H (1995) Different dose regimens of the mouse monoclonal antibody 17-1A for therapy of patients with metastatic colorectal carcinoma. Int J Oncol 7:1049
35. 2. J Immunol 145:760
36. Riethmüller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J, the German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma. Lancet 343:1177
37. Robins RA, Denton GWL, Hardcastle JD, Austin EB, Baldwin RW, Durrant LG (1991) Antitumour immune response and interleukin-2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res 51:5425
38. Saleh MN, LoBuglio AF, Wheeler RH, Rogers KJ, Haynes A, Lee JY, Kazaeli MB (1990) A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data. Cancer Immunol Immunother 32:185
39. Saleh M, Stapleton J, Khazaeli M, LoBuglio A (1993) Generation of a human anti-idiotypic antibody that mimics the GD2 antigen. J Immunol 151:3390
40. Sears HF, Herlyn D, Steplewski Z, Koprowski H (1986) Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma. Hybridoma 5:109
41. Shaw D, Khazaeli MB, Suu L, Ghrayeb J, Daddona P, McKinney, S, LoBuglio A (1987) Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen. J Immunol 138:4534
42. Sindelar WF, Maher MM, Herlyn D, Sears HF, Steplewski Z, Koprowski H (1986) Trial of therapy with monoclonal antibody 17-1A in pancreatic carcinoma: Preliminary results. Hybridoma 5:125
43. Steinitz M, Tamir S, Frödin J-E, Lefvert A-K, Mellstedt H (1988) Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumour patient treated with mouse monoclonal antibodies. J Immunol 141:3516
44. Steinitz M, Tamir S, Frödin J-E, Mellstedt H (1990) Human monoclonal anti-idiotypic antibodies against a murine monoclonal antibody (mAb17-1A) as an anti-tumour vaccine. In Borrebaeck CAK, Larrick JW (eds) Therapeutic monoclonal antibodies. Stockton Press, London, p 159
45. Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H, Linnenbach AJ (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87:3542
46. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin KM, Krummer PH (1989) Monoclonal antibody mediated tumour regression by induction of apoptosis. Science 245:301
47. Wettendorff M, Iliopoulos D, Tempero M, Kay D, DeFreitas E, Koprowski H, Herlyn D (1989) Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A. Proc Natl Acad Sci USA 86:3787